Kinesthetic stimulation versus methylxanthine for apnea in preterm infants
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Kinesthetic Stimulation Versus Methylxanthine for Apnea in Preterm Infants." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439386/all/Pharmacological_interventions_for_heart_failure_in_people_with_chronic_kidney_disease_New. Accessed 21 September 2023.
Kinesthetic stimulation versus methylxanthine for apnea in preterm infants. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439386/all/Pharmacological_interventions_for_heart_failure_in_people_with_chronic_kidney_disease_New. Accessed September 21, 2023.
Kinesthetic stimulation versus methylxanthine for apnea in preterm infants. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/439386/all/Pharmacological_interventions_for_heart_failure_in_people_with_chronic_kidney_disease_New
Kinesthetic Stimulation Versus Methylxanthine for Apnea in Preterm Infants [Internet]. In: Cochrane Abstracts. [cited 2023 September 21]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439386/all/Pharmacological_interventions_for_heart_failure_in_people_with_chronic_kidney_disease_New.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Kinesthetic stimulation versus methylxanthine for apnea in preterm infants
ID - 439386
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439386/all/Pharmacological_interventions_for_heart_failure_in_people_with_chronic_kidney_disease_New
DB - Evidence Central
DP - Unbound Medicine
ER -